| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.46 | 0.1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |